
|Articles|August 9, 2021
Pharmacy Clinical Pearl of the Day: PrEP for HIV
Author(s)Saro Arakelians, PharmD
Truvada is a medicine people at risk for HIV should take to prevent infection with the virus from various ways, such as sex or injection drug use.
Advertisement
Clinical Pearl of the Day: PrEP for HIV
- Emtricitabine and tenofovir disoproxil fumarate (Truvada) for pre-exposure prophylaxis (PrEP) is a once-daily prescription medicine for adults and adolescents at risk of HIV who weigh at least 77 pounds.
Explanation
- Truvada is a medicine people at risk for HIV should take to prevent infection with the virus from various ways, such as sex or injection drug use.
- PrEP consists of a combination of 2 antiretroviral drugs (tenofovir and emtricitabine), usually taken daily and often in combination with other HIV medicines.
- When taken consistently, the Centers for Disease Control and Prevention estimates that PrEP reduces the risk of HIV infection by up to 92%.
Reference
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tarlatamab-Dlle to Treat Adults With Extensive Stage Small Cell Lung Cancer
2
FDA Approves Sevabertinib for HER2-Mutant Non-Small Cell Lung Cancer
3
Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases
4
New Enlicitide Decanoate Data Show Significant LDL-C Reductions in At-Risk Patients
5














































































































































































































